These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24244679)

  • 1. Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells.
    Mogami T; Yokota N; Asai-Sato M; Yamada R; Koizume S; Sakuma Y; Yoshihara M; Nakamura Y; Takano Y; Hirahara F; Miyagi Y; Miyagi E
    PLoS One; 2013; 8(11):e80359. PubMed ID: 24244679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma.
    Takaya A; Peng WX; Ishino K; Kudo M; Yamamoto T; Wada R; Takeshita T; Naito Z
    Int J Oncol; 2015 Apr; 46(4):1573-81. PubMed ID: 25633807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin.
    Kim A; Enomoto T; Serada S; Ueda Y; Takahashi T; Ripley B; Miyatake T; Fujita M; Lee CM; Morimoto K; Fujimoto M; Kimura T; Naka T
    Int J Cancer; 2009 Nov; 125(10):2316-22. PubMed ID: 19598262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of annexin A4 in cancer.
    Yao H; Sun C; Hu Z; Wang W
    Front Biosci (Landmark Ed); 2016 Jun; 21(5):949-57. PubMed ID: 27100483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary.
    Kim A; Serada S; Enomoto T; Naka T
    Expert Opin Ther Targets; 2010 Sep; 14(9):963-71. PubMed ID: 20673185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexin IV is differentially expressed in clear cell carcinoma of the ovary.
    Miao Y; Cai B; Liu L; Yang Y; Wan X
    Int J Gynecol Cancer; 2009 Dec; 19(9):1545-9. PubMed ID: 19955935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and ANXA4/NF‑κB p50 complexes regulate cell proliferation, apoptosis and tumor progression in ovarian clear cell carcinoma.
    Liu J; Wang H; Zheng M; Deng L; Zhang X; Lin B
    Int J Mol Med; 2020 Dec; 46(6):2102-2114. PubMed ID: 33125094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexin A4 induces platinum resistance in a chloride-and calcium-dependent manner.
    Morimoto A; Serada S; Enomoto T; Kim A; Matsuzaki S; Takahashi T; Ueda Y; Yoshino K; Fujita M; Fujimoto M; Kimura T; Naka T
    Oncotarget; 2014 Sep; 5(17):7776-87. PubMed ID: 25277200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma.
    Itamochi H; Kigawa J; Terakawa N
    Cancer Sci; 2008 Apr; 99(4):653-8. PubMed ID: 18377417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model.
    Bartholomeusz C; Oishi T; Saso H; Akar U; Liu P; Kondo K; Kazansky A; Krishnamurthy S; Lee J; Esteva FJ; Kigawa J; Ueno NT
    Mol Cancer Ther; 2012 Feb; 11(2):360-9. PubMed ID: 22144664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A4 and cancer.
    Wei B; Guo C; Liu S; Sun MZ
    Clin Chim Acta; 2015 Jul; 447():72-8. PubMed ID: 26048190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers.
    Toyama A; Suzuki A; Shimada T; Aoki C; Aoki Y; Umino Y; Nakamura Y; Aoki D; Sato TA
    Cancer Sci; 2012 Apr; 103(4):747-55. PubMed ID: 22321069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lewis(y) antigen-mediated positive feedback loop induces and promotes chemotherapeutic resistance in ovarian cancer.
    Liu J; Zheng M; Qi Y; Wang H; Liu M; Liu Q; Lin B
    Int J Oncol; 2018 Oct; 53(4):1774-1786. PubMed ID: 30066907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
    Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A
    Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of annexin A4 is associated with chemoresistance in papillary serous adenocarcinoma of the ovary.
    Choi CH; Sung CO; Kim HJ; Lee YY; Song SY; Song T; Kim J; Kim TJ; Lee JW; Bae DS; Kim BG
    Hum Pathol; 2013 Jun; 44(6):1017-23. PubMed ID: 23290009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas.
    Miyamoto M; Takano M; Aoyama T; Soyama H; Yoshikawa T; Tsuda H; Furuya K
    J Gynecol Oncol; 2017 May; 28(3):e33. PubMed ID: 28382796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: cytoplasmic sequestration of CDK2 by p27.
    Itamochi H; Yoshida T; Walker CL; Bartholomeusz C; Aoki D; Ishihara H; Suzuki N; Kigawa J; Terakawa N; Ueno NT
    Gynecol Oncol; 2011 Sep; 122(3):641-7. PubMed ID: 21652059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma: a potential treatment strategy.
    Itamochi H; Kigawa J; Kanamori Y; Oishi T; Bartholomeusz C; Nahta R; Esteva FJ; Sneige N; Terakawa N; Ueno NT
    Mol Cancer Ther; 2007 Jan; 6(1):227-35. PubMed ID: 17218636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.
    Higashiguchi A; Yamada T; Susumu N; Mori T; Suzuki A; Aoki D; Sakamoto M
    Cancer Sci; 2007 Mar; 98(3):387-91. PubMed ID: 17270029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth-suppressing function of glypican-3 (GPC3) via insulin like growth factor II (IGF-II) signaling pathway in ovarian clear cell carcinoma cells.
    Sakurai M; Shibata K; Umezu T; Kajiyama H; Yamamoto E; Ino K; Nawa A; Kikkawa F
    Gynecol Oncol; 2010 Nov; 119(2):332-6. PubMed ID: 20701957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.